The monkeypox virus is only one mutation away from evading a key antiviral drug being used to treat at-risk patients, federal health officials are now warning — and they're urging doctors to be 'judicious' in prescribing the sought-after treatment.
The CDC has been closely tracking mutations in the virus to watch for potential variants that could be resistant to the monkeypox treatment. A portion of positive tests around the country are being forwarded to the agency for genetic sequencing.earlier this month of a"rare" mutation spotted in California that caused"false negative" results on some tests.
"We do know that there's a point mutation that could lead to resistance to tecovirimat or Tpoxx, which is our primary antiviral being used," said Bamrah Morris. by the National Institutes of Health to study the drug, instead of prescribing it themselves, when possible. protocol set up by the CDC. White House officials have touted their efforts to cut down on the paperwork in order to get the drug through this so-called"compassionate use" channel.early promising results collected from patients who have taken the drug through this protocol. Symptoms improved in three days on average.
"Data from randomized controlled trials are critically needed to address knowledge gaps related to efficacy, safety pharmacokinetics in humans with monkeypox, and to monitor for development of resistance to tecovirimat," the FDA's Dr. Adam Sherwat told doctors at a recentSiga Technologies, which manufactures tecovirimat, has been actively supporting the federal trial with supplies to study its drug.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Approves Eye Drops That Replace Reading GlassesThese drops could be a game changer.
Weiterlesen »
Skin lightening products are a 'regulatory black hole,' and the FDA is warning against using themThe FDA's Skin Facts! Initiative is aimed at promoting safe use of skin care products, urging people to be aware of non-prescription products marketed to lighten or bleach the skin.
Weiterlesen »
FDA to consider over-the-counter birth control pillFDA advisers are set to discuss a potential over-the-counter birth control pill at a November meeting.
Weiterlesen »
FDA Recalls Thing You Just AteSILVER SPRING, MD—Citing recently discovered health hazards associated with the product, the Food and Drug Administration announced Wednesday a recall of the thing you just ate. “Due to a concern regarding potential contaminants, the FDA is recalling the piece of food that, mere seconds ago, you placed in your mouth…
Weiterlesen »
Fast-growing cancer cell therapy developer Adicet Bio takes more space - San Francisco Business TimesThe FDA would decide whether its cancer cell therapy is approved, perhaps by the first half of next year.
Weiterlesen »
Monkeypox Can Cause Brain Inflammation, CDC SaysThe monkeypox virus can lead to neurologic complications such as brain inflammation, according to a new report published by the CDC’s Monkeypox Emergency Response Team.
Weiterlesen »